Press Release Press Release List

Utiai Partners with Bentham Science Journal, Endocrine, Metabolic & Immune Disorders – Drug Targets PRESS RELEASE DATE : 02-February-2022

Bentham Science has signed partnership with the Ukrainian Society of Specialists for Immunology, Allergology and Immunorehabilitation for its high impact journal, Endocrine, Metabolic & Immune Disorders – Drug Targets (JCR IF: 2.895). This partnership enables members of the society to publish their research in the journal with substantial concessions on Gold Open Access. The members can also avail personal subscription for the journal with discount.

The Ukrainian Society of Specialists in Immunology, Allergology and Immunorehabilitation (UTIAI) is an association of clinicians, scientists and health professionals, which was established to improve the health of people suffering from allergies and diseases of the immune system. With almost 600 members from all regions of Ukraine, UTIAI is the main source of expertise for all aspects of allergies and immune disorders.

UTIAI membership provides an opportunity to participate in annual conferences, workshops, schools and national congresses on clinical immunology and allergology. UTIAI members are involved in developing and updating standards and guidelines for care for patients with allergies and immune system disorders. For more information, please visit:

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at

About the Journal:

Endocrine, Metabolic & Immune Disorders - Drug Targets (JCR IF: 2.89)

This journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiota composition are welcome.

To learn more, please visit the website:

© 2024 Bentham Science Publishers | Privacy Policy